ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to reverse hair loss in women
Disease control Recruiting nowThis study is testing an investigational oral pill called VDPHL01 for women with genetic hair loss (female pattern baldness). It's a large, late-stage trial comparing the drug to a placebo to see if it safely increases hair count and improves appearance. The study lasts about 13 …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New scalp injections battle hair loss
Disease control Recruiting nowThis study aims to see which of two scalp injection treatments works better for common hair loss (androgenetic alopecia). It will compare a newer treatment called secretome injection with a more established one called platelet-rich plasma (PRP) injection. The study will measure c…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New lotion tested to fight hair loss in men
Disease control Recruiting nowThis study is testing whether a new hair lotion called Finlândia can help men with male pattern baldness grow more hair. It will compare the lotion's effects to current treatments over six months. The main goal is to see if it increases the number of hairs in a specific area of t…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New foam treatment tested to regrow Women's hair
Disease control Recruiting nowThis study is testing whether a 5% minoxidil foam applied once daily is better than a placebo foam at increasing hair count in women with hereditary hair loss. It involves 294 women and will measure hair growth in a specific area of the scalp over 24 weeks. The goal is to see if …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC